Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial

M.P. Steenbeek, M.G. Harmsen, N. Hoogerbrugge, M.A. de Jong, A.H.E.M. Maas, J.B. Prins, J. Bulten, S. Teerenstra, M.H.D. van Bommel, H.C. van Doorn, M.J.E. Mourits, M. van Beurden, R.P. Zweemer, K.N. Gaarenstroom, B.F.M. Slangen, M.M.A. Brood-van Zanten, M.C. Vos, J.M.J. Piek, L.R.C.W. van Lonkhuijzen, M.J.A. ApperlooS.F.P.J. Coppus, L.F.A.G. Massuger, J. IntHout, R.P.M.G. Hermens, J.A. de Hullu*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1203-1212
Number of pages10
JournalJAMA Oncology
Volume7
Issue number8
DOIs
Publication statusPublished - 1 Aug 2021

Keywords

  • RISK-REDUCING SURGERY
  • MUTATION CARRIERS
  • OVARIAN-CANCER
  • BREAST-CANCER
  • WOMEN
  • SYMPTOMS
  • THERAPY
  • IMPACT

Cite this